Skip to main content
Premium Trial:

Request an Annual Quote

BioModels, caGrid, Spotfire 2.1, Screener 5.5

Premium
The 10th release of the BioModels Database is available here. The new release includes 52 new models, of which 17 are included in the curated branch of the database. The database now includes 244 models representing 25,731 reactions and around 10,000 cross-references.
 

 
The National Cancer Institute’s Center for Biomedical Informatics and Information Technology has released version 1.2 of the caGrid core infrastructure here.
 
The new version includes several improvements, including a simplified service to handle large-scale data transfer for grid-based queries; integration with the latest releases of the Software Development Kit and the Common Security Module; a new web-based single sign-on framework, called WebSSO; and improvements in the usability of tools.
 

 
Spotfire, a division of Tibco Software, has released Tibco Spotfire 2.1. The latest release of the enterprise analytics software includes enhanced application programming interfaces and a “business mashups” capability that enables subject-matter experts “to leverage standard interfaces and business intelligence data to create user experiences … that speed insights and prompt better business decisions,” the company said.
 
Tibco said it expects to deliver Spotfire 2.1 in May. 
 

 
Genedata has released Screener 5.5, an updated version of its enterprise software for high-throughput and high-content screening analysis. Screener 5.5 features “easy integration of pharmacological fit models and advanced functionality for analyzing experiments with multiple readouts,” the company said.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.